| The FinancialContent Network SocialPicks Community | MarketMinute Monitor | MarketMinute Market Updates | MarketMinute Stock News |
|
After-Hours Movers 1/6: La Jolla (LJPC), NetScout (NTCT), Interwoven (IWOV) Higher; SMSC (SMSC), IXYS (IXYS), F5 (FFIV), Global Payments (GPN), Alcoa (AA) Lower |
|
| Jan 06, 2009 10:27 PM UTC |
|
Tracked Blogger
|
Via StreetInsider.com News Articles:
The After-Hours Movers lists the top gaining/declining stocks in after-hours trading: La Jolla Pharmaceutical (Nasdaq: LJPC) 166% HIGHER; BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and La Jolla have entered into an agreement to develop and commercialize Riquent, La Jolla's investigational drug for lupus nephritis, in the United States, Europe and all other territories of the world, excluding the Asia Pacific region. Under the terms of the agreement, BioMarin will receive a co-exclusive license to develop and commercialize Riquent and La Jolla could receive up to $289 million in cash through milestones and equity purchases by BioMarin. Specific payments include: $15 million
Read the rest of original post »
|
|
|
IN THE PRESS |
|
|
|
|
|
|
| About | RSS | Feedback | Contact Us | Terms of Service | Privacy |
© 2009 FinancialContent Services, Inc. |
|
Data powered by FinancialContent. All Rights Reserved. Quotes delayed at least 20 minutes unless otherwise indicated. |
|
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. |